CMS Director speaks at ACLA meeting; acknowledges that labs are alerting the agency to problems with Protecting Access to Medicare Act (PAMA) private payer market reporting, but did not say whether a delay in implementing either reporting or lab test fee cuts would be possible
WASHINGTON, DC—Last … [Read more...]

The DxMA Summit’s agenda will complement EWC’s and will explore disruptive technologies likely to be of great interest to medical laboratory leaders and pathology groups
Cybersecurity, wearable technology, and social media are the primary trends facing in vitro diagnostics (IVD) manufacturers and … [Read more...]

Pathologists and clinical laboratory managers may be overlooking ways that sales teams can add strategic value
As of January 1, 2018, the value of a top-performing clinical laboratory sales professional will increase because, on that date, labs will see a reduction in Medicare Part B clinical … [Read more...]

Clinical laboratories and pathology groups can benefit from developing a strategy for addressing negative Yelp reviews
In today’s wired world, clinical laboratories and anatomic pathology groups have a new challenge: what to do when unhappy patients go to social networking sites and post comments … [Read more...]

Many medical laboratories are working with vendors to optimize supply chain management and align it with patient outcomes
Even in today’s difficult financial environment, many local clinical laboratories and hospital lab outreach programs across the United States are prospering. Their financial … [Read more...]

Providing physicians with the clinical context and knowledge for the best use of specialty clinical laboratory tests helps this highly successful lab sales professional establish win-win client relationships
In support of the many local clinical laboratories and hospital lab outreach programs … [Read more...]

Medical laboratory managers are getting an important lesson in the power of price transparency to motivate patients to complain about arbitrarily high prices for healthcare services and products
By now, most clinical laboratory managers and pathologists know about the EpiPen pricing scandal. Simply … [Read more...]